Clínica Baviera, S.A. (BME:CBAV)
53.40
+0.40 (0.75%)
Oct 27, 2026, 11:23 AM CET
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €856.17 million as of October 26, 2026. It is the 10,338th most valuable company in the world and the 69th biggest in Spain. Its market cap has increased by 18.46% in one year.
Market Cap
856.17M
Enterprise Value
876.63M
Revenue
320.67M
Global Rank
Country Rank
#69 Spain
PE Ratio
18.60
ChartMarket Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 856.17M, an increase of 131.69%. That is a compound annual growth rate of 4.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 856.17M | 7.59% |
| Dec 31, 2025 | 795.80M | 59.55% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.38B |
| Laboratorios Farmaceuticos Rovi | 3.14B |
| Almirall | 2.26B |
| Faes Farma | 1.46B |
| Pharma Mar | 1.18B |
| Laboratorio Reig Jofre | 214.22M |
| Prim, S.A. | 211.75M |
| Oryzon Genomics | 204.91M |